Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area others gli'

Search results for: 'research area others gli'

Items 1-10 of 5068

Page
per page
  1. Rosiglitazone
    A4304 Rosiglitazone
     7 Citation
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  2. Vildagliptin (LAF-237)
    A4037 Vildagliptin (LAF-237)
    Summary: DPP-4 inhibitor
      ≥12.05 mg/mL
  3. Pioglitazone
    B2117 Pioglitazone
     1 Citation
    Summary: PPAR agonist
      insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL
  4. Sitagliptin (phosphate)
    C3966 Sitagliptin (phosphate)
    Summary: DPP-4 inhibitor
      ≥24.4 mg/mL
  5. Naveglitazar
    BA4466 Naveglitazar
    Summary: Naveglitazar (LY519818) is a peroxisome proliferator-activated receptor alpha-gamma dual.
  6. Luseogliflozin
    BA6954 Luseogliflozin
    Summary: Luseogliflozin (TS071) is a potent, selective, and orally active inhibitor of sodium-glucose cotransporter protein 2.
  7. Linagliptin (BI-1356)
    A4034 Linagliptin (BI-1356)
    Summary: DDP-4 inhibitor,highly potent and competitive
      insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL
  8. Alogliptin (SYR-322)
    A4038 Alogliptin (SYR-322)
     1 Citation
    Target: DPP-4
    Summary: DPP-4 inhibitor,potent and highly selective
  9. Repaglinide
    A5316 Repaglinide
    Summary: Kir6 (KATP) channel blocker
  10. Saxagliptin hydrate
    C6475 Saxagliptin hydrate
      ≥11.87 mg/mL

Items 1-10 of 5068

Page
per page